Selectin-mediated leukocyte trafficking during the development of autoimmune disease

Autoimmunity Reviews

Volumn 14, Issue 11, 2015, Pages 984-995

  Angiari, Stefano ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Autoimmunity; Inflammation; Leukocyte trafficking; Selectins; Therapeutic targets

Indexed keywords

LIGAND; SELECTIN; CYTOKINE;

ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CLINICAL TRIAL (TOPIC); DERMATITIS; DISEASE COURSE; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MULTIPLE SCLEROSIS; NONHUMAN; PROTEIN FUNCTION; PROTEIN INTERACTION; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; ANIMAL; CELL MOTION; CYTOLOGY; IMMUNOLOGY; LEUKOCYTE;

ANIMALS; AUTOIMMUNE DISEASES; CELL MOVEMENT; CYTOKINES; HUMANS; LEUKOCYTES; LIGANDS; SELECTINS;

EID: 84941260349     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2015.06.006     Document Type: Review

References (278)

1. Girard J.P., Moussion C., Förster R. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat Rev Immunol 2012, 12(11):762-773.
2. Luster A.D., Alon R., von Andrian U.H. Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 2005, 6(12):1182-1190.
3. Butcher E.C. The multistep model of leukocyte trafficking: a personal perspective from 15years later. In Leukocyte Trafficking: Molecular Mechanisms, Therapeutic Targets, and Methods (Hamann, A. and Engelhardt, B.) 2005, 3-13. Wiley-VCH.
4. Ley K., Laudanna C., Cybulsky M.I., Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007, 7(9):678-689.
5. Ley K., Kansas G.S. Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat Rev Immunol 2004, 4(5):325-335.
6. Zarbock A., Ley K., McEver R.P., Hidalgo A. Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. Blood 2011, 118(26):6743-6745.
7. Zarbock A., Kempf T., Wollert K.C., Vestweber D. Leukocyte integrin activation and deactivation: novel mechanisms of balancing inflammation. J Mol Med 2012, 90(4):353-359.
8. McEver R.P., Zhu C. Rolling cell adhesion. Annu Rev Cell Dev Biol 2010, 26:363-396.
9. Sperandio M., Gleissner C.A., Ley K. Glycosylation in immune cell trafficking. Immunol Rev 2009, 230(1):97-113.
10. Angiari S., Constantin G. Regulation of T cell trafficking by the T cell immunoglobulin and mucin domain 1 glycoprotein. Trends Mol Med 2014, 20(12):675-684.
11. Laszik Z., Jansen P.J., Cummings R.D., Tedder T.F., McEver R.P., Moore K.L. P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. Blood 1996, 88:3010-3021.
12. Norman K.E., Moore K.L., McEver R.P., Ley K. Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand-1. Blood 1995, 86(12):4417-4421.
13. Moore K.L., Patel K.D., Bruehl R.E., Li F., Johnson D.A., Lichenstein H.S., et al. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol 1995, 128(4):661-671.
14. Xia L., Sperandio M., Yago T., McDaniel J.M., Cummings R.D., Pearson-White S., et al. P-selectin glycoprotein ligand-1-deficient mice have impaired leukocyte tethering to E-selectin under flow. J Clin Invest 2002, 109(7):939-950.
15. Hirata T., Merrill-Skoloff G., Aab M., Yang J., Furie B.C., Furie B. P-selectin glycoprotein ligand 1 (PSGL-1) is a physiological ligand for E-selectin in mediating T helper 1 lymphocyte migration. J Exp Med 2000, 192(11):1669-1676.
16. Walcheck B., Moore K.L., McEver R.P., Kishimoto T.K. Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1. A mechanism that amplifies initial leukocyte accumulation of P-selectin in vitro. J Clin Invest 1996, 98(5):1081-1087.
17. Luscinskas F.W., Ding H., Tan P., Cumming D., Tedder T.F., Gerritsen M.E. L- and P-selectins, but not CD49d (VLA-4) integrins, mediate monocyte initial attachment to TNFalpha-activated vascular endothelium under flow in vitro. J Immunol 1996, 157(1):326-335.
18. Gerszten R.E., Garcia-Zepeda E.A., Lim Y.C., Yoshida M., Ding H.A., Gimbrone M.A., et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999, 398(6729):718-723.
19. León B., Ardavín C. Monocyte migration to inflamed skin and lymph nodes is differentially controlled by L-selectin and PSGL-1. Blood 2008, 111(6):3126-3130.
20. Austrup F., Vestweber D., Borges E., Löhning M., Bräuer R., Herz U., et al. P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflammed tissues. Nature 1997, 385(6611):81-83.
21. Borges E., Tietz W., Steegmaier M., Moll T., Hallmann R., Hamann A., et al. P-selectin glycoprotein ligand-1 (PSGL-1) on T helper 1 but not on T helper 2 cells binds to P-selectin and supports migration into inflamed skin. J Exp Med 1997, 185(3):573-578.
22. Mangan P.R., O'Quinn D., Harrington L., Bonder C.S., Kubes P., Kucik D.F., et al. Both Th1 and Th2 cells require P-selectin glycoprotein ligand-1 for optimal rolling on inflamed endothelium. Am J Pathol 2005, 167(6):1661-1675.
23. Merzaban J.S., Zuccolo J., Corbel S.Y., Williams M.J., Ziltener H.J. An alternate core 2 beta1,6-N-acetylglucosaminyltransferase selectively contributes to P-selectin ligand formation in activated CD8 T cells. J Immunol 2005, 174(7):4051-4059.
24. Asaduzzaman M., Mihaescu A., Wang Y., Sato T., Thorlacius H. P-selectin and P-selectin glycoprotein ligand 1 mediate rolling of activated CD8+ T cells in inflamed colonic venules. J Investig Med 2009, 57(7):765-768.
25. Jutila M.A., Bargatze R.F., Kurk S., Warnock R.A., Ehsani N., Watson S.R., et al. Cell surface P- and E-selectin support shear-dependent rolling of bovine gamma/delta T cells. J Immunol 1994, 153(9):3917-3928.
26. Diacovo T.G., Roth S.J., Morita C.T., Rosat J.P., Brenner M.B., Springer T.A. Interactions of human alpha/beta and gamma/delta T lymphocyte subsets in shear flow with E-selectin and P-selectin. J Exp Med 1996, 183(3):1193-1203.
27. Angiari S., Donnarumma T., Rossi B., Dusi S., Pietronigro E., Zenaro E., et al. TIM-1 glycoprotein binds the adhesion receptor P-selectin and mediates T cell trafficking during inflammation and autoimmunity. Immunity 2014, 40(4):542-553.
28. Abeynaike L.D., Deane J.A., Westhorpe C.L., Chow Z., Alikhan M.A., Kitching A.R., et al. Regulatory T cells dynamically regulate selectin ligand function during multiple challenge contact hypersensitivity. J Immunol 2014, 193(10):4934-4944.
29. Robert C., Fuhlbrigge R.C., Kieffer J.D., Ayehunie S., Hynes R.O., Cheng G., et al. Interaction of dendritic cells with skin endothelium: a new perspective on immunosurveillance. J Exp Med 1999, 189(4):627-636.
30. Kieffer J.D., Fuhlbrigge R.C., Armerding D., Robert C., Ferenczi K., Camphausen R.T., et al. Neutrophils, monocytes, and dendritic cells express the same specialized form of PSGL-1 as do skin-homing memory T cells: cutaneous lymphocyte antigen. Biochem Biophys Res Commun 2001, 285(3):577-587.
31. Silva Z., Tong Z., Cabral M.G., Martins C., Castro R., Reis C., et al. Sialyl Lewisx-dependent binding of human monocyte-derived dendritic cells to selectins. Biochem Biophys Res Commun 2011, 409(3):459-464.
32. Langer H.F., Daub K., Braun G., Schönberger T., May A.E., Schaller M., et al. Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitro. Arterioscler Thromb Vasc Biol 2007, 27(6):1463-1470.
33. Lim L.H., Burdick M.M., Hudson S.A., Mustafa F.B., Konstantopoulos K., Bochner B.S. Stimulation of human endothelium with IL-3 induces selective basophil accumulation in vitro. J Immunol 2006, 176(9):5346-5353.
34. Symon F.A., Lawrence M.B., Williamson M.L., Walsh G.M., Watson S.R., Wardlaw A.J. Functional and structural characterization of the eosinophil P-selectin ligand. J Immunol 1996, 157(4):1711-1719.
35. Boyce J.A., Mellor E.A., Perkins B., Lim Y.C., Luscinskas F.W. Human mast cell progenitors use alpha4-integrin, VCAM-1, and PSGL-1 E-selectin for adhesive interactions with human vascular endothelium under flow conditions. Blood 2002, 99(8):2890-2896.
36. Sheikh S., Parhar R.S., Bakheet R., Saleh S., Collison K., Al-Mohanna F. Immobilization of rolling NK cells on platelet-borne P-selectin under flow by proinflammatory stimuli, interleukin-12, and leukotriene B4. J Leukoc Biol 2004, 76(3):603-608.
37. Hidalgo A., Peired A.J., Wild M.K., Vestweber D., Frenette P.S. Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44. Immunity 2007, 26(4):477-489.
38. Katayama Y., Hidalgo A., Chang J., Peired A., Frenette P.S. CD44 is a physiological E-selectin ligand on neutrophils. J Exp Med 2005, 201(8):1183-1189.
39. Bonder C.S., Clark S.R., Norman M.U., Johnson P., Kubes P. Use of CD44 by CD4+ Th1 and Th2 lymphocytes to roll and adhere. Blood 2006, 107(12):4798-4806.
40. Fuhlbrigge R.C., King S.L., Sackstein R., Kupper T.S. CD43 is a ligand for E-selectin on CLA+ human T cells. Blood 2006, 107(4):1421-1426.
41. Matsumoto M., Shigeta A., Furukawa Y., Tanaka T., Miyasaka M., Hirata T. CD43 collaborates with P-selectin glycoprotein ligand-1 to mediate E-selectin-dependent T cell migration into inflamed skin. J Immunol 2007, 178(4):2499-2506.
42. Matsumoto M., Shigeta A., Miyasaka M., Hirata T. CD43 plays both antiadhesive and proadhesive roles in neutrophil rolling in a context-dependent manner. J Immunol 2008, 181(5):3628-3635.
43. Woodman R.C., Johnston B., Hickey M.J., Teoh D., Reinhardt P., Poon B.Y., et al. The functional paradox of CD43 in leukocyte recruitment: a study using CD43-deficient mice. J Exp Med 1998, 188(11):2181-2186.
44. Carlow D.A., Ziltener H.J. CD43 deficiency has no impact in competitive in vivo assays of neutrophil or activated T cell recruitment efficiency. J Immunol 2006, 177(9):6450-6459.
45. Silvescu C.I., Sackstein R. G-CSF induces membrane expression of a myeloperoxidase glycovariant that operates as an E-selectin ligand on human myeloid cells. Proc Natl Acad Sci U S A 2014, 111(29):10696-10701.
46. Aigner S., Ruppert M., Hubbe M., Sammar M., Sthoeger Z., Butcher E.C., et al. Heat stable antigen (mouse CD24) supports myeloid cell binding to endothelial and platelet P-selectin. Int Immunol 1995, 10:1557-1565.
47. Aigner S., Ramos C.L., Hafezi-Moghadam A., Lawrence M.B., Friederichs J., Altevogt P., et al. CD24 mediates rolling of breast carcinoma cells on P-selectin. FASEB J 1998, 12:1241-1251.
48. Myung J.H., Gajjar K.A., Pearson R.M., Launiere C.A., Eddington D.T., Hong S. Direct measurements on CD24-mediated rolling of human breast cancer MCF-7 cells on E-selectin. Anal Chem 2011, 83(3):1078-1083.
49. Fieger C.B., Sassetti C.M., Rosen S.D. Endoglycan, a member of the CD34 family, functions as an L-selectin ligand through modification with tyrosine sulfation and sialyl Lewis x. J Biol Chem 2003, 278(30):27390-27398.
50. Kerr S.C., Fieger C.B., Snapp K.R., Rosen S.D. Endoglycan, a member of the CD34 family of sialomucins, is a ligand for the vascular selectins. J Immunol 2008, 181(2):1480-1490.
51. Tang M.L., Steeber D.A., Zhang X.Q., Tedder T.F. Intrinsic differences in L-selectin expression levels affect T and B lymphocyte subset-specific recirculation pathways. J Immunol 1998, 160:5113-5121.
52. Sperandio M., Smith M.L., Forlow S.B., Olson T.S., Xia L., McEver R.P., et al. P selectin glycoprotein ligand-1 mediates L-selectin-dependent leukocyte rolling in venules. J Exp Med 2003, 197(10):1355-1363.
53. Patel K.D., McEver R.P. Comparison of tethering and rolling of eosinophils and neutrophils through selectins and P-selectin glycoprotein ligand-1. J Immunol 1997, 159(9):4555-4565.
54. Kitayama J., Fuhlbrigge R.C., Puri K.D., Springer T.A. P-selectin, L-selectin, and alpha 4 integrin have distinct roles in eosinophil tethering and arrest on vascular endothelial cells under physiological flow conditions. J Immunol 1997, 159(8):3929-3939.
55. McCarty O.J., Tien N., Bochner B.S., Konstantopoulos K. Exogenous eosinophil activation converts PSGL-1-dependent binding to CD18-dependent stable adhesion to platelets in shear flow. Am J Physiol Cell Physiol 2003, 284(5):C1223-C1234.
56. Lim Y.C., Snapp K., Kansas G.S., Camphausen R., Ding H., Luscinskas F.W. Important contributions of P-selectin glycoprotein ligand-1-mediated secondary capture to human monocyte adhesion to P-selectin, E-selectin, and TNF-alpha-activated endothelium under flow in vitro. J Immunol 1998, 161(5):2501-2508.
57. Berg E.L., McEvoy L.M., Berlin C., Bargatze R.F., Butcher E.C. L-selectin-mediated lymphocyte rolling on MAdCAM-1. Nature 1993, 366(6456):695-698.
58. Briskin M., Winsor-Hines D., Shyjan A., Cochran N., Bloom S., Wilson J., et al. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol 1997, 151(1):97-110.
59. Uchimura K., Rosen S.D. Sulfated L-selectin ligands as a therapeutic target in chronic inflammation. Trends Immunol 2006, 27(12):559-565.
60. Michie S.A., Streeter P.R., Bolt P.A., Butcher E.C., Picker L.J. The human peripheral lymph node vascular addressin. An inducible endothelial antigen involved in lymphocyte homing. Am J Pathol 1993, 143(6):1688-1698.
61. Compston A., Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517.
62. Rossi B., Angiari S., Zenaro E., Budui S.L., Constantin G. Vascular inflammation in central nervous system diseases: adhesion receptors controlling leukocyte-endothelial interactions. J Leukoc Biol 2011, 89(4):539-556.
63. Angiari S., Constantin G. Selectins and their ligands as potential immunotherapeutic targets in neurological diseases. Immunotherapy 2013, 11:1207-1220.
64. Ransohoff R.M., Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol 2012, 12(9):623-635.
65. Schneider-Hohendorf T., Rossaint J., Mohan H., Böning D., Breuer J., Kuhlmann T., et al. VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells. J Exp Med 2014, 211(9):1833-1846.
66. Piccio L., Rossi B., Scarpini E., Laudanna C., Giagulli C., Issekutz A.C., et al. Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric G(i)-linked receptors. J Immunol 2002, 168(4):1940-1949.
67. Kerfoot S.M., Kubes P. Overlapping roles of P-selectin and alpha 4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis. J Immunol 2002, 169(2):1000-1006.
68. Döring A., Wild M., Vestweber D., Deutsch U., Engelhardt B. E- and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice. J Immunol 2007, 179(12):8470-8479.
69. Zhao J., Gao Y., Cheng C., Yan M., Wang J. Upregulation of b-1,4-galactosyltransferase I in rat spinal cord with experimental autoimmune encephalomyelitis. J Mol Neurosci 2013, 49(3):437-445.
70. Washington R., Burton J., Todd R.F., Newman W., Dragovic L., Dore-Duffy P. Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis. Ann Neurol 1994, 35(1):89-97.
71. Lee S.J., Benveniste E.N. Adhesion molecule expression and regulation on cells of the central nervous system. J Neuroimmunol 1999, 98(2):77-88.
72. Galimberti D., Fenoglio C., Clerici R., Comi C., De Riz M., Rottoli M., et al. E-selectin A561C and G98T polymorphisms influence susceptibility and course of multiple sclerosis. J Neuroimmunol 2005, 165(1-2):201-205.
73. Rao R.M., Clarke J.L., Ortlepp S., Robinson M.K., Landis R.C., Haskard D.O. The S128R polymorphism of E-selectin mediates neuraminidase-resistant tethering of myeloid cells under shear flow. Eur J Immunol 2002, 32(1):251-260.
74. Rao R.M., Haskard D.O., Landis R.C. Enhanced recruitment of Th2 and CLA-negative lymphocytes by the S128R polymorphism of E-selectin. J Immunol 2002, 169(10):5860-5865.
75. Piccio L., Rossi B., Colantonio L., Grenningloh R., Gho A., Ottoboni L., et al. Efficient recruitment of lymphocytes in inflamed brain venules requires expression of cutaneous lymphocyte antigen and fucosyltransferase-VII. J Immunol 2005, 174(9):5805-5813.
76. Kerfoot S.M., Norman M.U., Lapointe B.M., Bonder C.S., Zbytnuik L., Kubes P. Reevaluation of P-selectin and alpha 4 integrin as targets for the treatment of experimental autoimmune encephalomyelitis. J Immunol 2006, 176(10):6225-6234.
77. Sathiyanadan K., Coisne C., Enzmann G., Deutsch U., Engelhardt B. PSGL-1 and E/P-selectins are essential for T-cell rolling in inflamed CNS microvessels but dispensable for initiation of EAE. Eur J Immunol 2014, 44(8):2287-2294.
78. Engelhardt B., Vestweber D., Hallmann R., Schulz M. E- and P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis. Blood 1997, 90(11):4459-4472.
79. Martín-Fontecha A., Baumjohann D., Guarda G., Reboldi A., Hons M., Lanzavecchia A., et al. CD40L+ CD4+ memory T cells migrate in a CD62P-dependent fashion into reactive lymph nodes and license dendritic cells for T cell priming. J Exp Med 2008, 205(11):2561-2574.
80. Langer H.F., Choi E.Y., Zhou H., Schleicher R., Chung K.J., Tang Z., et al. Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ Res 2012, 110(9):1202-1210.
81. Archelos J.J., Jung S., Rinner W., Lassmann H., Miyasaka M., Hartung H.P. Role of the leukocyte-adhesion molecule L-selectin in experimental autoimmune encephalomyelitis. J Neurol Sci 1998, 159(2):127-134.
82. Brocke S., Piercy C., Steinman L., Weissman I.L., Veromaa T. Antibodies to CD44 and integrin alpha 4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc Natl Acad Sci U S A 1999, 96(12):6896-6901.
83. Grewal I.S., Foellmer H.G., Grewal K.D., Wang H., Lee W.P., Tumas D., et al. CD62L is required on effector cells for local interactions in the CNS to cause myelin damage in experimental allergic encephalomyelitis. Immunity 2001, 14(3):291-302.
84. Li O., Liu J.Q., Zhang H., Zheng P., Liu Y., Bai X.F. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis. Scand J Immunol 2006, 64(2):117-124.
85. Uboldi C., Döring A., Alt C., Estess P., Siegelman M., Engelhardt B. L-selectin-deficient SJL and C57BL/6 mice are not resistant to experimental autoimmune encephalomyelitis. Eur J Immunol 2008, 38(8):2156-2167.
86. Deshpande P., King I.L., Segal B.M. IL-12 driven upregulation of P-selectin ligand on myelin-specific T cells is a critical step in an animal model of autoimmune demyelination. J Neuroimmunol 2006, 173(1-2):35-44.
87. Battistini L., Piccio L., Rossi B., Bach S., Galgani S., Gasperini C., et al. CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand. Blood 2003, 101(12):4775-4782.
88. Bahbouhi B., Berthelot L., Pettré S., Michel L., Wiertlewski S., Weksler B., et al. Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line. J Leukoc Biol 2009, 86(5):1049-1063.
89. Scalabrini D., Galimberti D., Fenoglio C., Comi C., De Riz M., Venturelli E., et al. P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis. Neurosci Lett 2005, 388(3):149-152.
90. Engelhardt B., Kempe B., Merfeld-Clauss S., Laschinger M., Furie B., Wild M.K., et al. P-selectin glycoprotein ligand 1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57BL/6 mice. J Immunol 2005, 175(2):1267-1275.
91. Angiari S., Rossi B., Piccio L., Zinselmeyer B.H., Budui S., Zenaro E., et al. Regulatory T cells suppress the late phase of the immune response in lymph nodes through P-selectin glycoprotein ligand-1. J Immunol 2013, 191(11):5489-5500.
92. Steffen B.J., Breier G., Butcher E.C., Schulz M., Engelhardt B. ICAM 1, VCAM 1, and MAdCAM 1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro. Am J Pathol 1996, 148(6):1819-1838.
93. Kanwar J.R., Harrison J.E., Wang D., Leung E., Mueller W., Wagner N., et al. Beta 7 integrins contribute to demyelinating disease of the central nervous system. J Neuroimmunol 2000, 103(2):146-152.
94. Kanwar J.R., Kanwar R.K., Wang D., Krissansen G.W. Prevention of a chronic progressive form of experimental autoimmune encephalomyelitis by an antibody against mucosal addressin cell adhesion molecule-1, given early in the course of disease progression. Immunol Cell Biol 2000, 78(6):641-645.
95. Kanwar J.R., Kanwar R.K., Krissansen G.W. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis. Brain 2004, 127(Pt 6):1313-1331.
96. Flynn K.M., Michaud M., Madri J.A. CD44 deficiency contributes to enhanced experimental autoimmune encephalomyelitis: a role in immune cells and vascular cells of the blood-brain barrier. Am J Pathol 2013, 182(4):1322-1336.
97. Ghazi-Visser L., Laman J.D., Nagel S., van Meurs M., van Riel D., Tzankov A., et al. CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells. FASEB J 2013, 27(9):3683-3701.
98. Deane J.A., Hickey M.J. Molecular mechanisms of leukocyte trafficking in T-cell-mediated skin inflammation: insights from intravital imaging. Expert Rev Mol Med 2009, 11. e25.
99. Berg E.L., Yoshino T., Rott L.S., Robinson M.K., Warnock R.A., Kishimoto T.K., et al. The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J Exp Med 1991, 174(6):1461-1466.
100. Picker L.J., Treer J.R., Ferguson-Darnell B., Collins P.A., Bergstresser P.R., Terstappen L.W. Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells. J Immunol 1993, 150(3):1122-1136.
101. Fuhlbrigge R.C., Kieffer J.D., Armerding D., Kupper T.S. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 1997, 389(6654):978-981.
102. Kupper T.S., Fuhlbrigge R.C. Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 2004, 4(3):211-222.
103. Nestle F.O., Kaplan D.H., Barker J. Psoriasis. N Engl J Med 2009, 361(5):496-509.
104. Groves R.W., Allen M.H., Barker J.N., Haskard D.O., MacDonald D.M. Endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation. Br J Dermatol 1991, 124(2):117-123.
105. Petzelbauer P., Pober J.S., Keh A., Braverman I.M. Inducibility and expression of microvascular endothelial adhesion molecules in lesional, perilesional, and uninvolved skin of psoriatic patients. J Invest Dermatol 1994, 103(3):300-305.
106. Veale D., Rogers S., Fitzgerald O. Immunolocalization of adhesion molecules in psoriatic arthritis, psoriatic and normal skin. Br J Dermatol 1995, 132(1):32-38.
107. Das P.K., de Boer O.J., Visser A., Verhagen C.E., Bos J.D., Pals S.T. Differential expression of ICAM-1, E-selectin and VCAM-1 by endothelial cells in psoriasis and contact dermatitis. Acta Derm Venereol Suppl 1994, 186:21-22.
108. Terajima S., Higaki M., Igarashi Y., Nogita T., Kawashima M. An important role of tumor necrosis factor-alpha in the induction of adhesion molecules in psoriasis. Arch Dermatol Res 1998, 290(5):246-252.
109. Abrams J.R., Kelley S.L., Hayes E., Kikuchi T., Brown M.J., Kang S., et al. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells. J Exp Med 2000, 192(5):681-694.
110. Wakita H., Takigawa M. E-selectin and vascular cell adhesion molecule-1 are critical for initial trafficking of helper-inducer/memory T cells in psoriatic plaques. Arch Dermatol 1994, 130(4):457-463.
111. Friedrich M., Bock D., Philipp S., Ludwig N., Sabat R., Wolk K., et al. Pan-selectin antagonism improves psoriasis manifestation in mice and man. Arch Dermatol Res 2006, 297(8):345-351.
112. Schön M.P., Krahn T., Schön M., Rodriguez M.L., Antonicek H., Schultz J.E., et al. Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation. Nat Med 2002, 8(4):366-372.
113. Bhushan M., Bleiker T.O., Ballsdon A.E., Allen M.H., Sopwith M., Robinson M.K., et al. Anti-E-selectin is ineffective in the treatment of psoriasis: a randomized trial. Br J Dermatol 2002, 146(5):824-831.
114. Arvilommi A.M., Salmi M., Kalimo K., Jalkanen S. Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1). Eur J Immunol 1996, 26(4):825-833.
115. Davison S.C., Ballsdon A., Allen M.H., Barker J.N. Early migration of cutaneous lymphocyte-associated antigen (CLA) positive T cells into evolving psoriatic plaques. Exp Dermatol 2001, 10(4):280-285.
116. Metzler G., Cerroni L., Schmidt H., Soyer H.P., Sill H., Kerl H. Leukemic cells within skin lesions of psoriasis in a patient with acute myelogenous leukemia. J Cutan Pathol 1997, 24(7):445-448.
117. Mitsui A., Tada Y., Shibata S., Kamata M., Hau C., Asahina A., et al. Deficiency of both L-selectin and ICAM-1 exacerbates imiquimod-induced psoriasis-like skin inflammation through increased infiltration of antigen presenting cells. Clin Immunol 2015, 157(1):43-55.
118. Bieber T. Atopic dermatitis. Ann Dermatol 2010, 22(2):125-137.
119. Wakita H., Sakamoto T., Tokura Y., Takigawa M. E-selectin and vascular cell adhesion molecule-1 as critical adhesion molecules for infiltration of T lymphocytes and eosinophils in atopic dermatitis. J Cutan Pathol 1994, 21(1):33-39.
120. de Vries I.J., Langeveld-Wildschut E.G., van Reijsen F.C., Dubois G.R., van den Hoek J.A., Bihari I.C. Adhesion molecule expression on skin endothelia in atopic dermatitis: effects of TNF-alpha and IL-4. J Allergy Clin Immunol 1998, 102(3):461-468.
121. Sigurdsson V., de Vries I.J., Toonstra J., Bihari I.C., Thepen T., Bruijnzeel-Koomen C.A., et al. Expression of VCAM-1, ICAM-1, E-selectin, and P-selectin on endothelium in situ in patients with erythroderma, mycosis fungoides and atopic dermatitis. J Cutan Pathol 2000, 27(9):436-440.
122. Satoh T., Kaneko M., Wu M.H., Yokozeki H., Nishioka K. Contribution of selectin ligands to eosinophil recruitment into the skin of patients with atopic dermatitis. Eur J Immunol 2002, 32(5):1274-1281.
123. Biedermann T., Schwärzler C., Lametschwandtner G., Thoma G., Carballido-Perrig N., Kund J., et al. Targeting CLA/E-selectin interactions prevents CCR4-mediated recruitment of human Th2 memory cells to human skin in vivo. Eur J Immunol 2002, 32(11):3171-3180.
124. Chen L., Lin S.X., Amin S., Overbergh L., Maggiolino G., Chan L.S. VCAM-1 blockade delays disease onset, reduces disease severity and inflammatory cells in an atopic dermatitis model. Immunol Cell Biol 2010, 88(3):334-342.
125. Fujita T., Fujimoto M., Matsushita T., Shimada Y., Hasegawa M., Kuwano Y., et al. Phase-dependent roles of E-selectin during chronic contact hypersensitivity responses. Am J Pathol 2007, 170(5):1649-1658.
126. Shimada Y., Hasegawa M., Kaburagi Y., Hamaguchi Y., Komura K., Saito E., et al. L-selectin or ICAM-1 deficiency reduces an immediate-type hypersensitivity response by preventing mast cell recruitment in repeated elicitation of contact hypersensitivity. J Immunol 2003, 170(8):4325-4334.
127. Gonda A., Gál I., Szántó S., Sarraj B., Glant T.T., Hunyadi J., et al. CD44, but not L-selectin, is critically involved in leucocyte migration into the skin in a murine model of allergic dermatitis. Exp Dermatol 2005, 14(9):700-708.
128. Abraham C., Cho J.H. Inflammatory bowel disease. N Engl J Med 2009, 361(21):2066-2078.
129. Vainer B., Nielsen O.H. Changed colonic profile of P-selectin, platelet-endothelial cell adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1), ICAM-2, and ICAM-3 in inflammatory bowel disease. Clin Exp Immunol 2000, 121(2):242-247.
130. Schürmann G.M., Bishop A.E., Facer P., Vecchio M., Lee J.C., Rampton D.S., et al. Increased expression of cell adhesion molecule P-selectin in active inflammatory bowel disease. Gut 1995, 36(3):411-418.
131. Oshitani N., Hato F., Kitagawa S., Masuyama J., Higuchi K., Matsumoto T., et al. Expression of 4C8 antigen, a novel transendothelial migration-associated molecule on activated T lymphocytes, in inflammatory bowel disease. J Pathol 2002, 197(5):589-594.
132. Ohtani H., Nakamura S., Watanabe Y., Fukushima K., Mizoi T., Kimura M., et al. Light and electron microscopic immunolocalization of endothelial leucocyte adhesion molecule-1 in inflammatory bowel disease. Morphological evidence of active synthesis and secretion into vascular lumen. Virchows Arch A Pathol Anat Histopathol 1992, 420(5):403-409.
133. Koizumi M., King N., Lobb R., Benjamin C., Podolsky D.K. Expression of vascular adhesion molecules in inflammatory bowel disease. Gastroenterology 1992, 103(3):840-847.
134. Pooley N., Ghosh L., Sharon P. Up-regulation of E-selectin and intercellular adhesion molecule-1 differs between Crohn's disease and ulcerative colitis. Dig Dis Sci 1995, 40(1):219-225.
135. Oshitani N., Campbell A., Bloom S., Kitano A., Kobayashi K., Jewell D.P. Adhesion molecule expression on vascular endothelium and nitroblue tetrazolium reducing activity in human colonic mucosa. Scand J Gastroenterol 1995, 30(9):915-920.
136. Cellier C., Patey N., Fromont-Hankard G., Cervoni J.P., Leborgne M., Chaussade S., et al. In-situ endothelial cell adhesion molecule expression in ulcerative colitis. E-selectin in-situ expression correlates with clinical, endoscopic and histological activity and outcome. Eur J Gastroenterol Hepatol 1997, 9(12):1197-1203.
137. Bhatti M., Chapman P., Peters M., Haskard D., Hodgson H.J. Visualising E-selectin in the detection and evaluation of inflammatory bowel disease. Gut 1998, 43(1):40-47.
138. Lazaris A.C., Dicoglou C., Tseleni-Balafouta S., Paraskevakou H., Davaris P.S. In situ expression of E-selectin and intercellular adhesion molecule-1 in chronic inflammatory diseases of the gastrointestinal tract. APMIS 1999, 107(9):819-827.
139. Thomas P.D., Forbes A., Price A.B., Nicholls R.J., Ciclitira P.J. Differential expression of cell adhesion molecules within inflamed ileal pouch mucosa: relationship to recruited cell subtypes. Eur J Gastroenterol Hepatol 2002, 14(2):137-144.
140. Vainer B., Nielsen O.H., Horn T. Expression of E-selectin, sialyl Lewis X, and macrophage inflammatory protein-1alpha by colonic epithelial cells in ulcerative colitis. Dig Dis Sci 1998, 43(3):596-608.
141. Sans M., Salas A., Soriano A., Prats N., Gironella M., Pizcueta P., et al. Differential role of selectins in experimental colitis. Gastroenterology 2001, 120(5):1162-1172.
142. Sun F.F., Lai P.S., Yue G., Yin K., Nagele R.G., Tong D.M., et al. Pattern of cytokine and adhesion molecule mRNA in hapten-induced relapsing colon inflammation in the rat. Inflammation 2001, 25(1):33-45.
143. Salas A., Gironella M., Salas A., Soriano A., Sans M., Iovanna J., et al. Nitric oxide supplementation ameliorates dextran sulfate sodium-induced colitis in mice. Lab Invest 2002, 82(5):597-607.
144. Cuzzocrea S., Mazzon E., Serraino I., Dugo L., Centorrino T., Ciccolo A., et al. Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats. Eur J Pharmacol 2001, 431(1):91-102.
145. McCafferty D.M., Smith C.W., Granger D.N., Kubes P. Intestinal inflammation in adhesion molecule-deficient mice: an assessment of P-selectin alone and in combination with ICAM-1 or E-selectin. J Leukoc Biol 1999, 66(1):67-74.
146. Wan M.X., Riaz A.A., Schramm R., Wang Y., Vestweber D., Menger M.D., et al. Leukocyte rolling is exclusively mediated by P-selectin in colonic venules. Br J Pharmacol 2002, 135(7):1749-1756.
147. Gironella M., Mollà M., Salas A., Soriano A., Sans M., Closa D., et al. The role of P-selectin in experimental colitis as determined by antibody immunoblockade and genetically deficient mice. J Leukoc Biol 2002, 72(1):56-64.
148. Arndt H., Palitzsch K.D., Anderson D.C., Rusche J., Grisham M.B., Granger D.N. Leucocyte-endothelial cell adhesion in a model of intestinal inflammation. Gut 1995, 37(3):374-379.
149. Yoshida N., Yamaguchi T., Nakagawa S., Nakamura Y., Naito Y., Yoshikawa T. Role of P-selectin and intercellular adhesion molecule-1 in TNB-induced colitis in rats. Digestion 2001, 63(Suppl. 1):81-86.
150. Hamamoto N., Maemura K., Hirata I., Murano M., Sasaki S., Katsu K. Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leucocyte adhesion molecule-1 (ELAM-1) or intercellular adhesion molecule-1 (ICAM-1)). Clin Exp Immunol 1999, 117(3):462-468.
151. Zhang X.W., Liu Q., Thorlacius H. Inhibition of selectin function and leukocyte rolling protects against dextran sodium sulfate-induced murine colitis. Scand J Gastroenterol 2001, 36(3):270-275.
152. Beck P.L., Ihara E., Hirota S.A., MacDonald J.A., Meng D., Nanthakumar N.N., et al. Exploring the interplay of barrier function and leukocyte recruitment in intestinal inflammation by targeting fucosyltransferase VII and trefoil factor 3. Am J Physiol Gastrointest Liver Physiol 2010, 299(1):G43-G53.
153. Wong P.Y., Yue G., Yin K., Liu P., Lin M., Rodriguez A., et al. Anti-P-selectin antibody exacerbated inflammatory responses in acetic acid-induced colitis. Adv Exp Med Biol 1997, 433:323-326.
154. Rivera-Nieves J., Olson T., Bamias G., Bruce A., Solga M., Knight R.F., et al. L-selectin, alpha 4 beta 1, and alpha 4 beta 7 integrins participate in CD4+ T cell recruitment to chronically inflamed small intestine. J Immunol 2005, 174(4):2343-2352.
155. Kurmaeva E., Boktor M., Zhang S., Bao R., Berney S., Ostanin D.V. Roles of T cell-associated L-selectin and β7 integrins during induction and regulation of chronic colitis. Inflamm Bowel Dis 2013, 19(12):2547-2559.
156. Kühl A.A., Kakirman H., Janotta M., Dreher S., Cremer P., Pawlowski N.N., et al. Aggravation of different types of experimental colitis by depletion or adhesion blockade of neutrophils. Gastroenterology 2007, 133(6):1882-1892.
157. Kobayashi M., Hoshino H., Masumoto J., Fukushima M., Suzawa K., Kageyama S., et al. GlcNAc6ST-1-mediated decoration of MAdCAM-1 protein with L-selectin ligand carbohydrates directs disease activity of ulcerative colitis. Inflamm Bowel Dis 2009, 15(5):697-706.
158. Suzawa K., Kobayashi M., Sakai Y., Hoshino H., Watanabe M., Harada O., et al. Preferential induction of peripheral lymph node addressin on high endothelial venule-like vessels in the active phase of ulcerative colitis. Am J Gastroenterol 2007, 102(7):1499-1509.
159. Kobayashi M., Hoshino H., Suzawa K., Sakai Y., Nakayama J., Fukuda M. Two distinct lymphocyte homing systems involved in the pathogenesis of chronic inflammatory gastrointestinal diseases. Semin Immunopathol 2012, 34(3):401-413.
160. Brown J.B., Cheresh P., Zhang Z., Ryu H., Managlia E., Barrett T.A. P-selectin glycoprotein ligand-1 is needed for sequential recruitment of T-helper 1 (Th1) and local generation of Th17 T cells in dextran sodium sulfate (DSS) colitis. Inflamm Bowel Dis 2012, 18(2):323-332.
161. Vowinkel T., Wood K.C., Stokes K.Y., Russell J., Tailor A., Anthoni C., et al. Mechanisms of platelet and leukocyte recruitment in experimental colitis. Am J Physiol Gastrointest Liver Physiol 2007, 293(5):G1054-G1060.
162. Mori M., Salter J.W., Vowinkel T., Krieglstein C.F., Stokes K.Y., Granger D.N. Molecular determinants of the prothrombogenic phenotype assumed by inflamed colonic venules. Am J Physiol Gastrointest Liver Physiol 2005, 288(5):G920-G926.
163. Collins C.E., Cahill M.R., Newland A.C., Rampton D.S. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 1994, 106(4):840-845.
164. Fägerstam J.P., Whiss P.A., Ström M., Andersson R.G. Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease. Inflamm Res 2000, 49(9):466-472.
165. Kayo S., Ikura Y., Suekane T., Shirai N., Sugama Y., Ohsawa M., et al. Close association between activated platelets and neutrophils in the active phase of ulcerative colitis in humans. Inflamm Bowel Dis 2006, 12(8):727-735.
166. Inoue T., Tsuzuki Y., Matsuzaki K., Matsunaga H., Miyazaki J., Hokari R., et al. Blockade of PSGL-1 attenuates CD14+ monocytic cell recruitment in intestinal mucosa and ameliorates ileitis in SAMP1/Yit mice. J Leukoc Biol 2005, 77(3):287-295.
167. Rivera-Nieves J., Burcin T.L., Olson T.S., Morris M.A., McDuffie M., Cominelli F., et al. Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis. J Exp Med 2006, 203(4):907-917.
168. Rijcken E.M., Laukoetter M.G., Anthoni C., Meier S., Mennigen R., Spiegel H.U., et al. Immunoblockade of PSGL-1 attenuates established experimental murine colitis by reduction of leukocyte rolling. Am J Physiol Gastrointest Liver Physiol 2004, 287(1):G115-G124.
169. Nuñez-Andrade N., Lamana A., Sancho D., Gisbert J.P., Gonzalez-Amaro R., Sanchez-Madrid F., et al. P-selectin glycoprotein ligand-1 modulates immune inflammatory responses in the enteric lamina propria. J Pathol 2011, 224(2):212-221.
170. Matsumoto M., Miyasaka M., Hirata T. P-selectin glycoprotein ligand-1 negatively regulates T-cell immune responses. J Immunol 2009, 183(11):7204-7211.
171. Wittig B., Schwärzler C., Föhr N., Günthert U., Zöller M. Curative treatment of an experimentally induced colitis by a CD44 variant V7-specific antibody. J Immunol 1998, 161(3):1069-1073.
172. Wittig B.M., Johansson B., Zöller M., Schwärzler C., Günthert U. Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7). J Exp Med 2000, 191(12):2053-2064.
173. Farkas S., Hornung M., Sattler C., Anthuber M., Gunthert U., Herfarth H., et al. Short-term treatment with anti-CD44v7 antibody, but not CD44v4, restores the gut mucosa in established chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol 2005, 142(2):260-267.
174. Rosenberg W.M., Prince C., Kaklamanis L., Fox S.B., Jackson D.G., Simmons D.L., et al. Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease. Lancet 1995, 345(8959):1205-1209.
175. Reinisch W., Heider K.H., Oberhuber G., Dejaco C., Müllner M., Adolf G.R., et al. Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease. Gut 1998, 43(3):375-382.
176. Macdonald D.C., Leir S.H., Brooks C., Sanders E., Lackie P., Rosenberg W. CD44 isoform expression on colonic epithelium mediates lamina propria lymphocyte adhesion and is controlled by Th1 and Th2 cytokines. Eur J Gastroenterol Hepatol 2003, 15(10):1101-1110.
177. Brazil J.C., Lee W.Y., Kolegraff K.N., Nusrat A., Parkos C.A., Louis N.A. Neutrophil migration across intestinal epithelium: evidence for a role of CD44 in regulating detachment of migrating cells from the luminal surface. J Immunol 2010, 185(11):7026-7036.
178. Brazil J.C., Liu R., Sumagin R., Kolegraff K.N., Nusrat A., Cummings R.D., et al. α3/4 Fucosyltransferase 3-dependent synthesis of Sialyl Lewis A on CD44 variant containing exon 6 mediates polymorphonuclear leukocyte detachment from intestinal epithelium during transepithelial migration. J Immunol 2013, 191(9):4804-4817.
179. Collins C.B., Ho J., Wilson T.E., Wermers J.D., Tlaxca J.L., Lawrence M.B., et al. CD44 deficiency attenuates chronic murine ileitis. Gastroenterology 2008, 135(6):1993-2002.
180. Hansen M.P., Matheis N., Kahaly G.J. Type 1 diabetes and polyglandular autoimmune syndrome: a review. World J Diabetes 2015, 6(1):67-79.
181. Anderson M.S., Bluestone J.A. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 2005, 23:447-485.
182. Hänninen A., Jalkanen S., Salmi M., Toikkanen S., Nikolakaros G., Simell O. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest 1992, 90(5):1901-1910.
183. Hänninen A., Taylor C., Streeter P.R., Stark L.S., Sarte J.M., Shizuru J.A., et al. Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium. J Clin Invest 1993, 92(5):2509-2515.
184. Dong H., Burke S.D., Croy B.A. Vascular addressins in the uterus and pancreas of type 1 diabetic mice in early pregnancy. Placenta 2008, 29(2):201-209.
185. Faveeuw C., Gagnerault M.C., Lepault F. Expression of homing and adhesion molecules in infiltrated islets of Langerhans and salivary glands of nonobese diabetic mice. J Immunol 1994, 152(12):5969-5978.
186. Phillips J.M., Haskins K., Cooke A. MAdCAM-1 is needed for diabetes development mediated by the T cell clone, BDC-2.5. Immunology 2005, 116(4):525-531.
187. Xu B., Cook R.E., Michie S.A. Alpha4beta7 integrin/MAdCAM-1 adhesion pathway is crucial for B cell migration into pancreatic lymph nodes in nonobese diabetic mice. J Autoimmun 2010, 35(2):124-129.
188. Yang X.D., Sytwu H.K., McDevitt H.O., Michie S.A. Involvement of beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in the development of diabetes in obese diabetic mice. Diabetes 1997, 46(10):1542-1547.
189. Fabien N., Bergerot I., Orgiazzi J., Thivolet C. Lymphocyte function associated antigen-1, integrin alpha 4, and L-selectin mediate T-cell homing to the pancreas in the model of adoptive transfer of diabetes in NOD mice. Diabetes 1996, 45(9):1181-1186.
190. Lepault F., Gagnerault M.C., Faveeuw C., Bazin H., Boitard C. Lack of L-selectin expression by cells transferring diabetes in NOD mice: insights into the mechanisms involved in diabetes prevention by Mel-14 antibody treatment. Eur J Immunol 1995, 25(6):1502-1507.
191. Yang X.D., Karin N., Tisch R., Steinman L., McDevitt H.O. Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very late antigen 4 adhesion receptors. Proc Natl Acad Sci U S A 1993, 90(22):10494-10498.
192. Friedline R.H., Wong C.P., Steeber D.A., Tedder T.F., Tisch R. L-selectin is not required for T cell-mediated autoimmune diabetes. J Immunol 2002, 168(6):2659-2666.
193. Mora C., Grewal I.S., Wong F.S., Flavell R.A. Role of L-selectin in the development of autoimmune diabetes in non-obese diabetic mice. Int Immunol 2004, 16(2):257-264.
194. Herbelin A., Gombert J.M., Lepault F., Bach J.F., Chatenoud L. Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse. J Immunol 1998, 161(5):2620-2628.
195. Lepault F., Gagnerault M.C. Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice. J Immunol 2000, 164(1):240-247.
196. Johnson G.G., Mikulowska A., Butcher E.C., McEvoy L.M., Michie S.A. Anti-CD43 monoclonal antibody L11 blocks migration of T cells to inflamed pancreatic islets and prevents development of diabetes in nonobese diabetic mice. J Immunol 1999, 163(10):5678-5685.
197. Weiss L., Slavin S., Reich S., Cohen P., Shuster S., Stern R., et al. Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody. Proc Natl Acad Sci U S A 2000, 97(1):285-290.
198. Li C.R., Mueller E.E., Bradley L.M. Targeting CD44 augments the efficacy of Tregs in autoimmune diabetes. Immunol Lett 2015, 163(2):199-205.
199. Milde K.F., Alonso M., Kong S.S., Alejandro R., Mintz D.H., Pastori R.L. Expression of a specific subset of CD44 variant transcripts in NOD pancreatic islets. Diabetes 1996, 45(6):718-724.
200. McInnes I.B., Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011, 365(23):2205-2219.
201. Wright H.L., Moots R.J., Edwards S.W. The multifactorial role of neutrophils in rheumatoid arthritis. Nat Rev Rheumatol 2014, 10(10):593-601.
202. Johnson B.A., Haines G.K., Harlow L.A., Koch A.E. Adhesion molecule expression in human synovial tissue. Arthritis Rheum 1993, 36(2):137-146.
203. Elewaut D., De Keyser F., De Wever N., Baeten D., Van Damme N., Verbruggen G., et al. A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers. Ann Rheum Dis 1998, 57(8):480-486.
204. Veihelmann A., Harris A.G., Krombach F., Schütze E., Refior H.J., Messmer K. In vivo assessment of synovial microcirculation and leukocyte-endothelial cell interaction in mouse antigen-induced arthritis. Microcirculation 1999, 6(4):281-290.
205. Ishikawa H., Nishibayashi Y., Kita K., Ohno O., Imura S., Hirata S. Adhesion molecules in the lymphoid cell distribution in rheumatoid synovial membrane. Bull Hosp Jt Dis 1993, 53(2):23-28.
206. el-Gabalawy H., Gallatin M., Vazeux R., Peterman G., Wilkins J. Expression of ICAM-R (ICAM-3), a novel counter-receptor for LFA-1, in rheumatoid and nonrheumatoid synovium. Comparison with other adhesion molecules. Arthritis Rheum 1994, 37(6):846-854.
207. Chapman P.T., Jamar F., Keelan E.T., Peters A.M., Haskard D.O. Use of a radiolabeled monoclonal antibody against E-selectin for imaging of endothelial activation in rheumatoid arthritis. Arthritis Rheum 1996, 39(8):1371-1375.
208. Wikaningrum R., Highton J., Parker A., Coleman M., Hessian P.A., Roberts-Thompson P.J., et al. Pathogenic mechanisms in the rheumatoid nodule: comparison of proinflammatory cytokine production and cell adhesion molecule expression in rheumatoid nodules and synovial membranes from the same patient. Arthritis Rheum 1998, 41(10):1783-1797.
209. Brand D.D., Latham K.A., Rosloniec E.F. Collagen-induced arthritis. Nat Protoc 2007, 2(5):1269-1275.
210. Hersmann G.H., Kriegsmann J., Simon J., Hüttich C., Bräuer R. Expression of cell adhesion molecules and cytokines in murine antigen-induced arthritis. Cell Adhes Commun 1998, 6(1):69-82.
211. Gompels L.L., Madden L., Lim N.H., Inglis J.J., McConnell E., Vincent T.L., et al. In vivo fluorescence imaging of E-selectin: quantitative detection of endothelial activation in a mouse model of arthritis. Arthritis Rheum 2011, 63(1):107-117.
212. Birner U., Issekutz T.B., Walter U., Issekutz A.C. The role of alpha(4) and LFA-1 integrins in selectin-independent monocyte and neutrophil migration to joints of rats with adjuvant arthritis. Int Immunol 2000, 12(2):141-150.
213. Schmitt-Sody M., Metz P., Klose A., Gottschalk O., Zysk S., Hausdorf J., et al. In vivo interactions of platelets and leucocytes with the endothelium in murine antigen-induced arthritis: the role of P-selectin. Scand J Rheumatol 2007, 36(4):311-319.
214. Sumariwalla P.F., Malfait A.M., De Benedetti Feldmann M. P-selectin glycoprotein ligand 1 therapy ameliorates established collagen-induced arthritis in DBA/1 mice partly through the suppression of tumour necrosis factor. Clin Exp Immunol 2004, 136(1):67-75.
215. Wang F., Wang N.S., Yan C.G., Li J.H., Tang L.Q. The significance of platelet activation in rheumatoid arthritis. Clin Rheumatol 2007, 26(5):768-771.
216. Schmitt-Sody M., Metz P., Gottschalk O., Birkenmaier C., Zysk S., Veihelmann A., et al. Platelet P-selectin is significantly involved in leukocyte-endothelial cell interaction in murine antigen-induced arthritis. Platelets 2007, 18(5):365-372.
217. Postigo A.A., Garcia-Vicuña R., Diaz-Gonzalez F., Arroyo A.G., De Landázuri M.O., Chi-Rosso G., et al. Increased binding of synovial T lymphocytes from rheumatoid arthritis to endothelial-leukocyte adhesion molecule-1 (ELAM-1) and vascular cell adhesion molecule-1 (VCAM-1). J Clin Invest 1992, 89(5):1445-1452.
218. De Benedetti F., Pignatti P., Biffi M., Bono E., Wahid S., Ingegnoli F., et al. Increased expression of alpha(1,3)-fucosyltransferase-VII and P-selectin binding of synovial fluid T cells in juvenile idiopathic arthritis. J Rheumatol 2003, 30(7):1611-1615.
219. Volin M.V., Szekanecz Z., Halloran M.M., Woods J.M., Magua J., Damergis J.A., et al. PECAM-1 and leukosialin (CD43) expression correlate with heightened inflammation in rat adjuvant-induced arthritis. Exp Mol Pathol 1999, 66(3):211-219.
220. Mukasa R., Homma T., Hosono O., Yoshino S., Nishioka K., Fukuda M., et al. Human T lymphocyte populations which bind to P- or E-selectin are enriched with cells expressing core 2 O-glycans. Immunol Lett 1999, 67(2):117-124.
221. Brennan F.R., Mikecz K., Glant T.T., Jobanputra P., Pinder S., Bavington C., et al. CD44 expression by leucocytes in rheumatoid arthritis and modulation by specific antibody: implications for lymphocyte adhesion to endothelial cells and synoviocytes in vitro. Scand J Immunol 1997, 45(2):213-220.
222. Halloran M.M., Szekanecz Z., Barquin N., Haines G.K., Koch A.E. Cellular adhesion molecules in rat adjuvant arthritis. Arthritis Rheum 1996, 39(5):810-819.
223. Mikecz K., Brennan F.R., Kim J.H., Glant T.T. Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nat Med 1995, 1(6):558-563.
224. Mikecz K., Dennis K., Shi M., Kim J.H. Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis. Arthritis Rheum 1999, 42(4):659-668.
225. Nedvetzki S., Walmsley M., Alpert E., Williams R.O., Feldmann M., Naor D. CD44 involvement in experimental collagen-induced arthritis (CIA). J Autoimmun 1999, 13(1):39-47.
226. Zeidler A., Bräuer R., Thoss K., Bahnsen J., Heinrichs V., Jablonski-Westrich D., et al. Therapeutic effects of antibodies against adhesion molecules in murine collagen type II-induced arthritis. Autoimmunity 1995, 21(4):245-252.
227. Kelleher D., Murphy A., Hall N., Omary M.B., Kearns G., Long A., et al. Expression of CD44 on rheumatoid synovial fluid lymphocytes. Ann Rheum Dis 1995, 54(7):566-570.
228. Verdrengh M., Holmdahl R., Tarkowski A. Administration of antibodies to hyaluronan receptor (CD44) delays the start and ameliorates the severity of collagen II arthritis. Scand J Immunol 1995, 42(3):353-358.
229. Szántó S., Gál I., Gonda A., Glant T.T., Mikecz K. Expression of L-selectin, but not CD44, is required for early neutrophil extravasation in antigen-induced arthritis. J Immunol 2004, 172(11):6723-6734.
230. Sarraj B., Ludányi K., Glant T.T., Finnegan A., Mikecz K. Expression of CD44 and L-selectin in the innate immune system is required for severe joint inflammation in the proteoglycan-induced murine model of rheumatoid arthritis. J Immunol 2006, 177(3):1932-1940.
231. Stoop R., Gál I., Glant T.T., McNeish J.D., Mikecz K. Trafficking of CD44-deficient murine lymphocytes under normal and inflammatory conditions. Eur J Immunol 2002, 32(9):2532-2542.
232. Stoop R., Kotani H., McNeish J.D., Otterness I.G., Mikecz K. Increased resistance to collagen-induced arthritis in CD44-deficient DBA/1 mice. Arthritis Rheum 2001, 44(12):2922-2931.
233. Hutás G., Bajnok E., Gál I., Finnegan A., Glant T.T., Mikecz K. CD44-specific antibody treatment and CD44 deficiency exert distinct effects on leukocyte recruitment in experimental arthritis. Blood 2008, 112(13):4999-5006.
234. Bullard D.C., Mobley J.M., Justen J.M., Sly L.M., Chosay J.G., Dunn C.J., et al. Acceleration and increased severity of collagen-induced arthritis in P-selectin mutant mice. J Immunol 1999, 163(5):2844-2849.
235. Ruth J.H., Amin M.A., Woods J.M., He X., Samuel S., Yi N., Haas C.S., Koch A.E., Bullard D.C., et al. Accelerated development of arthritis in mice lacking endothelial selectins. Arthritis Res Ther 2005, 7(5):R959-R970.
236. Nedvetzki S., Gonen E., Assayag N., Reich R., Williams R.O., Thurmond R.L., et al. RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy. Proc Natl Acad Sci U S A 2004, 101(52):18081-18086.
237. Grober J.S., Bowen B.L., Ebling H., Athey B., Thompson C.B., Fox D.A., et al. Monocyte-endothelial adhesion in chronic rheumatoid arthritis. In situ detection of selectin and integrin-dependent interactions. J Clin Invest 1993, 91(6):2609-2619.
238. Middleton J., Americh L., Gayon R., Julien D., Mansat M., Mansat P., et al. A comparative study of endothelial cell markers expressed in chronically inflamed human tissues: MECA-79, Duffy antigen receptor for chemokines, von Willebrand factor, CD31, CD34, CD105 and CD146. J Pathol 2005, 206(3):260-268.
239. Pablos J.L., Santiago B., Tsay D., Singer M.S., Palao G., Galindo M., et al. A HEV-restricted sulfotransferase is expressed in rheumatoid arthritis synovium and is induced by lymphotoxin-alpha/beta and TNF-alpha in cultured endothelial cells. BMC Immunol 2005, 6:6.
240. Yang J., Rosen S.D., Bendele P., Hemmerich S. Induction of PNAd and N-acetylglucosamine 6-O-sulfotransferases 1 and 2 in mouse collagen-induced arthritis. BMC Immunol 2006, 7:12.
241. Jin C., Ekwall A.K., Bylund J., Björkman L., Estrella R.P., Whitelock J.M., et al. Human synovial lubricin expresses sialyl Lewis x determinant and has L-selectin ligand activity. J Biol Chem 2012, 287(43):35922-35933.
242. Rahman A., Isenberg D.A. Systemic lupus erythematosus. N Engl J Med 2008, 358(9):929-939.
243. Belmont H.M., Buyon J., Giorno R., Abramson S. Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited. Arthritis Rheum 1994, 37(3):376-383.
244. Pallis M., Robson D.K., Haskard D.O., Powell R.J. Distribution of cell adhesion molecules in skeletal muscle from patients with systemic lupus erythematosus. Ann Rheum Dis 1993, 52(9):667-671.
245. Bruijn J.A., Dinklo N.J. Distinct patterns of expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and endothelial-leukocyte adhesion molecule-1 in renal disease. Lab Invest 1993, 69(3):329-335.
246. Segawa C., Wada T., Takaeda M., Furuichi K., Matsuda I., Hisada Y., et al. In situ expression and soluble form of P-selectin in human glomerulonephritis. Kidney Int 1997, 52(4):1054-1063.
247. Harari O.A., Marshall D., McHale J.F., Ahmed S., Haskard D.O. Limited endothelial E- and P-selectin expression in MRL/lpr lupus-prone mice. Rheumatology (Oxford) 2001, 40(8):889-895.
248. Marshall D., Dangerfield J.P., Bhatia V.K., Larbi K.Y., Nourshargh S., Haskard D.O. MRL/lpr lupus-prone mice show exaggerated ICAM-1-dependent leucocyte adhesion and transendothelial migration in response to TNF-alpha. Rheumatology (Oxford) 2003, 42(8):929-934.
249. Nakatani K., Fujii H., Hasegawa H., Terada M., Arita N., Ito M.R., et al. Endothelial adhesion molecules in glomerular lesions: association with their severity and diversity in lupus models. Kidney Int 2004, 65(4):1290-1300.
250. Nakatani K., Yoshimoto S., Asai O., Sakan H., Terada M., Saito Y., et al. Enhanced expression of the soluble form of E-selectin attenuates progression of lupus nephritis and vasculitis in MRL/lpr mice. Immun Inflamm Dis 2013, 1(1):37-46.
251. Stielke S., Keilhoff G., Kirches E., Mertens P.R., Neumann K.H., Tsokos G.C., et al. Adhesion molecule expression precedes brain damages of lupus-prone mice and correlates with kidney pathology. J Neuroimmunol 2012, 252(1-2):24-32.
252. Hickey M.J., Bullard D.C., Issekutz A., James W.G. Leukocyte-endothelial cell interactions are enhanced in dermal postcapillary venules of MRL/fas(lpr) (lupus-prone) mice: roles of P- and E-selectin. J Immunol 2002, 168(9):4728-4736.
253. James W.G., Hutchinson P., Bullard D.C., Hickey M.J. Cerebral leucocyte infiltration in lupus-prone MRL/MpJ-fas lpr mice-roles of intercellular adhesion molecule-1 and P-selectin. Clin Exp Immunol 2006, 144(2):299-308.
254. He X., Schoeb T.R., Panoskaltsis-Mortari A., Zinn K.R., Kesterson R.A., Zhang J., et al. Deficiency of P-selectin or P-selectin glycoprotein ligand-1 leads to accelerated development of glomerulonephritis and increased expression of CC chemokine ligand 2 in lupus-prone mice. J Immunol 2006, 177(12):8748-8756.
255. Takahashi S., Araki K., Araki M., Ito M.R., Nakatani K., Fujii H., et al. Suppression of experimental lupus nephritis by aberrant expression of the soluble E-selectin gene. Pathol Int 2002, 52(3):175-180.
256. El-Magadmi M., Alansari A., Teh L.S., Ordi J., Gül A., Inanc M., et al. Association of the A561C E-selectin polymorphism with systemic lupus erythematosus in 2 independent populations. J Rheumatol 2001, 28(12):2650-2652.
257. Farkas L., Beiske K., Lund-Johansen F., Brandtzaeg P., Jahnsen F.L. Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 2001, 159(1):237-243.
258. Wang Y., Meng J., Wang X., Liu S., Shu Q., Gao L., et al. Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients. Scand J Immunol 2008, 67(1):63-70.
259. Nozaki Y., Kitching A.R., Akiba H., Yagita H., Kinoshita K., Funauchi M., et al. Endogenous Tim-1 promotes severe systemic autoimmunity and renal disease MRL-Fas(lpr) mice. Am J Physiol Renal Physiol 2014, 306(10):F1210-F1221.
260. Katsumoto T.R., Whitfield M.L., Connolly M.K. The pathogenesis of systemic sclerosis. Annu Rev Pathol 2011, 6:509-537.
261. Assassi S., Wu M., Tan F.K., Chang J., Graham T.A., Furst D.E., et al. Skin gene expression correlates of severity of interstitial lung disease in systemic sclerosis. Arthritis Rheum 2013, 65(11):2917-2927.
262. Koch A.E., Kronfeld-Harrington L.B., Szekanecz Z., Cho M.M., Haines G.K., Harlow L.A., et al. In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease. Pathobiology 1993, 61(5-6):239-246.
263. Gruschwitz M.S., Hornstein O.P., von Den Driesch P. Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity. Arthritis Rheum 1995, 38(2):184-189.
264. Claman H.N., Giorno R.C., Seibold J.R. Endothelial and fibroblastic activation in scleroderma. The myth of the "uninvolved skin". Arthritis Rheum 1991, 34(12):1495-1501.
265. Sollberg S., Peltonen J., Uitto J., Jimenez S.A. Elevated expression of beta 1 and beta 2 integrins, intercellular adhesion molecule 1, and endothelial leukocyte adhesion molecule 1 in the skin of patients with systemic sclerosis of recent onset. Arthritis Rheum 1992, 35(3):290-298.
266. Kräling B.M., Jimenez S.A., Sorger T., Maul G.G. Isolation and characterization of microvascular endothelial cells from the adult human dermis and from skin biopsies of patients with systemic sclerosis. Lab Invest 1994, 71(5):745-754.
267. Hebbar M., Lassalle P., Janin A., Vanhée D., Bisiau S., Hatron P.Y., et al. E-selectin expression in salivary endothelial cells and sera from patients with systemic sclerosis. Role of resident mast cell-derived tumor necrosis factor alpha. Arthritis Rheum 1995, 38(3):406-412.
268. Hebbar M., Gillot J.M., Hachulla E., Lassalle P., Hatron P.Y., Devulder B., et al. Early expression of E-selectin, tumor necrosis factor alpha, and mast cell infiltration in the salivary glands of patients with systemic sclerosis. Arthritis Rheum 1996, 39(7):1161-1165.
269. Yoshizaki A., Yanaba K., Iwata Y., Komura K., Ogawa A., Akiyama Y., et al. Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model. J Immunol 2010, 185(4):2502-2515.
270. Pérez-Frías A., González-Tajuelo R., Núñez-Andrade N., Tejedor R., García-Blanco M.J., Vicente-Rabaneda E., et al. Development of an autoimmune syndrome affecting the skin and internal organs in P-selectin glycoprotein ligand 1 leukocyte receptor-deficient mice. Arthritis Rheum 2014, 66(11):3178-3189.
271. Griffith J.W., Luster A.D. Targeting cells in motion: migrating toward improved therapies. Eur J Immunol 2013, 43:1430-1435.
272. Sigmundsdottir H., Butcher E.C. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat Immunol 2008, 9:981-987.
273. Islam S.A., Luster A.D. T cell homing to epithelial barriers in allergic disease. Nat Med 2012, 18(5):705-715.
274. Beeh K.M., Beier J., Meyer M., Buhl R., Zahlten R., Wolff G. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial. Pulm Pharmacol Ther 2006, 19(4):233-241.
275. Kirsten A., Watz H., Kretschmar G., Pedersen F., Bock D., Meyer-Sabellek W., et al. Efficacy of the pan-selectin antagonist Bimosiamose on ozone-induced airway inflammation in healthy subjects - a double blind, randomized, placebo-controlled, cross-over clinical trial. Pulm Pharmacol Ther 2011, 24(5):555-558.
276. Watz H., Bock D., Meyer M., Schierhorn K., Vollhardt K., Woischwill C., et al. Inhaled pan-selectin antagonist Bimosiamose attenuates airway inflammation in COPD. Pulm Pharmacol Ther 2013, 26(2):265-270.
277. Kerr K.M., Auger W.R., Marsh J.J., Comito R.M., Fedullo R.L., Smits G.J., et al. The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy. Am J Respir Crit Care Med 2000, 162(1):14-20.
278. Telen M.J., Wun T., McCavit T.L., De Castro L.M., Krishnamurti L., Lanzkron S., et al. Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use. Blood 2015, 125(17):2656-2664.